The Future of Pharmacometrics with Dr. Nathan Teuscher

In this episode of BioTalk Unzipped, hosts Gregory Austin and Chad Briscoe welcome Dr. Nathan Teuscher, a seasoned expert in clinical pharmacology and pharmacometrics. The conversation explores Nathan's career journey, the innovative charity Light the World, and the transformative role of AI in drug development. They discuss the challenges and opportunities presented by AI, particularly in automating data analysis and rethinking traditional reporting methods in the pharmaceutical industry. The episode emphasizes the potential for small companies to leverage cloud-based tools and APIs to enhance efficiency and drive innovation in drug development. In this conversation, the speakers explore the intersection of data analysis, AI tools, and advancements in gene editing with organ transplants.

Chapters

00:00 Episode Preview

00:55 Introduction to BioTalk Unzipped

02:06 Charity Spotlight: Light of the World

04:51 Nathan Teuscher's Career Journey

07:34 Differentiating AI Types in Life Science

12:41 Challenges with Large Language Models

15:39 Rethinking Reporting in Pharma

17:56 The Future of AI and Analytics in Pharma?

18:52 Leveraging APIs (Application Programming Interfaces) for Small Companies

23:05 Leveraging Data, AI, and APIs in 3 Dimensions

26:22 NEW NEWS! - Gene Editing Breakthroughs in Medicine

How to reach us:

Light the World Charity - Church of Jesus Christ Latter Day Saints

https://www.churchofjesuschrist.org/comeuntochrist/light-the-world

Nathan Teuscher

https://www.linkedin.com/in/nathanteuscher/

Aplos Analytics - https://aplosanalytics.com/

Nathan Teuscher’s Podcast: Clinical Pharmacology Podcast

https://teuschersolutions.com/

Collaboration with BioTalk Unzipped (Ep. 40)

https://podcasts.apple.com/us/podcast/collaboration-with-biotalk-unzipped-ep-40/id1695617234?i=1000682122951

Dr. Chad Briscoe

https://www.linkedin.com/in/chadbriscoe/

Celerion - https://www.celerion.com/

Gregory Austin

https://www.linkedin.com/in/gregoryaustin1/

ECI - https://eci-rx.com /

Sound Bites

"We don't need to write reports anymore."

Takeaways

• Nathan Teuscher has over 20 years of experience in clinical pharmacology and pharmacometrics.
• 
  
• Light the World charity offers unique giving machines for donations.
• 
  
• AI can automate repetitive tasks in drug development, freeing up human capital for innovation.
• 
  
• There are two types of AI: large language models and automated data analysis.
• 
  
• Large language models can be unreliable in scientific contexts.
• 
  
• Pharmaceutical companies spend significant resources on report writing, which may not add value.
• 
  
• Small companies can leverage APIs to access standardized calculations and data analysis.
• 
  
• The pharmaceutical industry is often insular, limiting the potential of AI.
• 
  
• AI could potentially eliminate the need for extensive written reports in drug development.
• 
  
• Collaboration and data sharing are crucial for advancing AI in the pharmaceutical industry. Leveraging data effectively requires combining various data sets and tools.
• 
  
• The evolution of AI tools is crucial for navigating new technologies.
• 
  
• Gene editing represents a significant breakthrough in organ transplantation.
• 
  
• 
  

New News Story:

• A woman in the US is the third person to receive a gene-edited pig kidney
• 
  
• 
  
• https://www.technologyreview.com/2024/12/17/1108905/a-woman-in-the-us-is-the-third-person-to-receive-a-gene-edited-pig-kidney/
• 
  
• 
  
• 
  

Image Credits

• Pig Kidney, https://ny1.com/nyc/all-boroughs/news/2023/08/16/pig-kidney-works-in-a-donated-body-for-over-a-month--a-step-toward-animal-human-transplants
• 
  
• 
  

Keywords

BioTalk, pharmacology, AI in pharma, drug development, pharmacometrics, software development, clinical research, Light the World, charity, data analysis, AI tools, gene editing, kidney transplant, pharmaceuticals, virtual trials, healthcare innovation, drug development, patient engagement, medical technology, drug dosage, oncology, FDA approval, cell therapy, immunocompromised, collaboration, success, clinical pharmacology, podcast, healthcare